✦ LIBER ✦

A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria

✍ Scribed by Elissa Malkin; Jinhong Hu; Zhen Li; Zhihui Chen; Xinling Bi; Zarifah Reed; Filip Dubovsky; Jian Liu; Qiang Wang; Xuegong Pan; Tom Chen; Birgitte Giersing; Yu Xu; Xin Kang; Jun Gu; Qian Shen; Kathryn Tucker; Eveline Tierney; Weiqing Pan; Carole Long; Zhifang Cao

Book ID: 116960995
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 766 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.09.081

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1 safety and immunogenicity trial

Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults

✍ Mark A. Pierce; Ruth D. Ellis; Laura B. Martin; Elissa Malkin; Eveline Tierney; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Glutamate-rich protein (GLURP) induces a

Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial

✍ Cornelus C. Hermsen; Danielle F. Verhage; Denise S.C. Telgt; Karina Teelen; J. T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 722 KB

Phase I trial of two recombinant vaccine

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-119) and T helper epitopes of tetanus toxoid

✍ W.A Keitel; K.E Kester; R.L Atmar; A.C White Jr; N.H Bond; C.A Holland; U Krzych 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase 1 randomized double-blind safety a

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

✍ José A. Stoute; Joash Gombe; Mark R. Withers; Joram Siangla; Denise McKinney; Me 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 325 KB

A randomized and controlled Phase 1 stud

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults

✍ Issaka Sagara; Ruth D. Ellis; Alassane Dicko; Mohamed B. Niambele; Beh Kamate; O 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 358 KB

Phase I dose escalation safety and immun

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research

✍ Mark E. Polhemus; Alan J. Magill; James F. Cummings; Kent E. Kester; Chris F. Oc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 646 KB